Sequence-Dependent Potentiation of Paclitaxel-Mediated Apoptosis in Human Leukemia Cells by Inhibitors of the Mitogen-Activated Protein Kinase Kinase/Mitogen-Activated Protein Kinase Pathway
Authors:
- Chunrong YuCYChunrong Yu
- Shujie WangSWShujie Wang
- Paul DentPDPaul Dent
- Steven GrantSGSteven Grant
- 1 July 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 60 (1) , 143-154
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- During Apoptosis of HL-60 and U-937 Cells Caspases Are Activated Independently of Dissipation of Mitochondrial Electrochemical PotentialExperimental Cell Research, 2000
- The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cellsLeukemia Research, 2000
- Serine/Threonine Protein Kinases and ApoptosisExperimental Cell Research, 2000
- The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariantNature Cell Biology, 2000
- Microtubule Inhibitors Elicit Differential Effects on MAP Kinase (JNK, ERK, and p38) Signaling Pathways in Human KB-3 Carcinoma CellsExperimental Cell Research, 2000
- The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a reviewCancer Chemotherapy and Pharmacology, 1999
- Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivoNature Medicine, 1999
- MAP kinase pathwaysProgress in Biophysics and Molecular Biology, 1999
- Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937)Biochemical Pharmacology, 1998
- PD 98059 Prevents Establishment of the Spindle Assembly Checkpoint and Inhibits the G2-M Transition in Meiotic but Not Mitotic Cell Cycles inXenopusExperimental Cell Research, 1998